Cambridge University Extends License to InforSense Software | GenomeWeb
NEW YORK (GenomeWeb News) - InforSense said today that it has extended and expanded a license agreement with Cambridge University’s Department of Pathology for four of its software platforms.
 
Under the agreement, Cambridge has extended its license for the company’s InforSense and BioSense products, and its GenSense and Genome Wide Association Study modules.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.